FDA Drug recall D-0007-2018
Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefie…
- FDA Drug
- Class III
- terminated
- Published 2017-10-18
On 2017-10-18 the FDA classified a Class III recall of Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefie… by Boehringer Ingelheim Pharmaceuticals, citing labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0007-2018 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2017-09-22 |
| Published | 2017-10-18 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Boehringer Ingelheim Pharmaceuticals |
| Distribution | CO, OH |
Product
Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01
Reason
Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
Identifiers
| code_info | Lot 754037 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0007-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.